Georgia Bio Becomes Georgia Life Sciences

Georgia Bio Becomes Georgia Life Sciences

Rebrand reflects organization’s growth state and key expansion of the sector


FOR IMMEDIATE RELEASE


Atlanta, GA (January 22, 2025) – Georgia Bio announced that it has rebranded the organization as Georgia Life Sciences, bringing renewed focus and support to the core strengths of the business and academic organizations within Georgia’s life sciences and healthcare communities.


As the leading advocate for the state’s dynamic and diverse life sciences sector, Georgia Life Sciences promotes policy development, community programs, industry initiatives, and events, as well as the research and products of its associated member and partner organizations.


“This is a key milestone for the association. Our rapidly growing membership is a testament to the strength of our community," said Maria Thacker-Goethe, President and CEO, Georgia Life Sciences. “We recognized that our association's brand should reflect and amplify the essence of our organization and project the impact of our success on behalf of our members. As we determined that a refresh to our visual branding was needed, it became evident that our naming convention no longer reflected our mission in serving Georgia’s expansive and growing life sciences sector.”


Georgia Life Sciences will maintain their established leadership role as a convenor in Georgia by continuing to advocate for effective national, state and local policies that protect and preserve innovation, attract public and private partnerships, improve educational opportunities, and promote the renowned research institutions and cutting-edge technological resources that has established the state as a viable leader in life sciences innovation.


Georgia Life Sciences supports its membership through several organizational areas of focus:

  • Policy & Advocacy: Advance life sciences innovation through policy and advocacy leadership at all levels of government
  • Workforce & Talent: Establish Georgia as a center for excellence in life science workforce training and talent development
  • Economic Development: Provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in Georgia
  • Innovation and Entrepreneurship: Serve as catalyst for life sciences innovation by helping entrepreneurs build successful ventures, access capital, and identify non-dilutive funding opportunities
  • Networking and Collaboration: Foster connection by convening thought leaders around relevant industry topics and peer-to-peer exchange
  • Cost Savings: Curated discounts on products and services critical to running a successful business


# # #

About Georgia Life Sciences

Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at www.galifesciences.org.


CONTACT:

Stacey Bowlin

Georgia Life Sciences

sbowlin@galifesciences.org

703-402-7608

September 11, 2025
Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.
By Maria Thacker Goethe September 5, 2025
Protecting U.S. Leadership in Agricultural Biotechnology
By Maria Thacker Goethe August 29, 2025
Celebrating the Next Generation of Scientific Breakthroughs in Georgia
MORE POSTS